Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 6 | Journal of Biomedical Science

Fig. 6

From: PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation

Fig. 6

DUSP19 dephosphorylates VEGFR3 via a direct receptor tyrosine kinase–protein phosphatase interaction. A Western blot analysis of the VEGFR3 immunoprecipitates showed that DUSP19 was present in the immunocomplex from QGP-1 cells with knockdown of vector control (shLuc) but not present in the immunocomplex from QGP-1 cells with DUSP19 knockdown (left panel). Western blot analysis of the DUSP19 immunoprecipitates showed that VEGFR3 was present in the immunocomplex from QGP-1 cells with knockdown of vector control (shLuc) but not present in the immunocomplex from QGP-1 cells with VEGFR3 knockdown (right panel). Immunoprecipitation with IgG was used as negative control. B VEGFR3 and DUSP19 were shown to be colocalized on the cell membrane of QGP-1 cells by immunofluorescence staining. C Confocal microscope images of XY and XZ sections. D The phospho-signal of the phospho-VEGFR3 peptide was reduced by the addition of recombinant DUSP19 (P = 0.021, Wilcoxon rank-sum test)

Back to article page